Cubist Systematic Strategies, LLC Uro Gen Pharma Ltd. Transaction History
Cubist Systematic Strategies, LLC
- $15.8 Billion
- Q3 2024
A detailed history of Cubist Systematic Strategies, LLC transactions in Uro Gen Pharma Ltd. stock. As of the latest transaction made, Cubist Systematic Strategies, LLC holds 13,361 shares of URGN stock, worth $143,096. This represents 0.0% of its overall portfolio holdings.
Number of Shares
13,361
Previous 44,949
70.28%
Holding current value
$143,096
Previous $754,000
77.59%
% of portfolio
0.0%
Previous 0.01%
Shares
14 transactions
Others Institutions Holding URGN
# of Institutions
130Shares Held
35.9MCall Options Held
22KPut Options Held
93.8K-
Rtw Investments, LP New York, NY3.79MShares$40.6 Million0.77% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA3.74MShares$40 Million0.09% of portfolio
-
Menora Mivtachim Holdings Ltd.2.3MShares$24.7 Million0.19% of portfolio
-
Black Rock Inc. New York, NY2.19MShares$23.5 Million0.0% of portfolio
-
Morgan Stanley New York, NY2.18MShares$23.4 Million0.0% of portfolio
About UroGen Pharma Ltd.
- Ticker URGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 22,740,500
- Market Cap $244M
- Description
- UroGen Pharma Ltd., a biotechnology company, engages in the development and commercialization novel solutions for specialty cancers and urothelial diseases. It offers RTGel, a polymeric biocompatible and reverse thermal gelation hydrogel to improve therapeutic profiles of existing drugs; and Jelmyto for pyelocalyceal solution. The company's lead...